OnKure Therapeutics, Inc. - Class A (OKUR) earnings
OKUR earnings moved a median of -1.75% by the close. Quarterly and annual OKUR reports and results, each read against the price at its own news timestamp. Back to the OKUR overview →
15 measured OKUR earnings events.
Where these OKUR earnings landedvs 15 measured OKUR earnings reactions
| Middle 50% of OKUR earnings reactions | -5.97% to +0.90% |
|---|---|
| Median reaction (to close) | -1.75% |
| Measured reactions | 15 |
Point-in-time · zero look-ahead
Half of the 15 OKUR earnings events with a measured close landed between -5.97% and +0.90%; 40% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q OnKure Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -2.72% | -1.75% | |
| OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights | Press release | -2.72% | -1.75% | |
| Form 10-Q OnKure Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | -0.48% | +0.73% | |
| OnKure Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights | Press release | -0.48% | +0.73% | |
| Form 10-Q OnKure Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -6.45% | -6.22% | |
| OnKure Therapeutics Reports First Quarter 2026 Financial Results | Press release | -6.45% | -6.22% | |
| Form 10-K OnKure Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -2.94% | +1.07% | |
| Form 10-Q OnKure Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | -4.54% | |
| OnKure Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Business Update | Press release | +0.00% | -4.54% | |
| Form 10-Q OnKure Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +1.12% | +9.59% | |
| OnKure Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Business Update | Press release | +1.12% | +9.59% | |
| Form 10-Q OnKure Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.20% | -10.80% | |
| OnKure Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights | Press release | -3.20% | -10.80% | |
| Form 10-K OnKure Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.00% | -5.71% | |
| Form 10-Q OnKure Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +3.18% | +3.41% |
Keep exploring
More OKUR: analyst actions → · SEC filings → · OKUR overview →